Trial Profile
A retrospective study to evaluate efficacy of golimumab in patients with severe uveitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- 28 Nov 2015 New trial record